Squamous Cell Anal Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-07-26
Clinical Trial Update: Cetuximab + Avelumab or Avelumab Alone for Unresectable, Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (SCCAC) Progressed After at Least One Line of Systemic Treatment (CARACAS) [Phase 2]
Phase 2 trial evaluating cetuximab plus avelumab or avelumab alone in unresectable, locally advanced or metastatic squamous cell anal carcin…